secwatch / observer
8-K filed February 10, 2026, 6:59 PM ET ticker FMNB CIK 0000709337
M&A confidence high sentiment neutral materiality 0.75

Farmers National and Middlefield shareholders approve merger; close expected Q1 2026

FARMERS NATIONAL BANC CORP /OH/

item 5.03item 5.07item 7.01item 9.01

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001437749-26-003620
form_type
8-K
ticker
FMNB
cik
0000709337
company_name
FARMERS NATIONAL BANC CORP /OH/
filed_at
2026-02-10T23:59:59+00:00
discovered_at
2026-05-14T18:02:37.510859+00:00
generated_at
2026-05-16T03:43:55.145268+00:00
sec_items
["5.03", "5.07", "7.01", "9.01"]
event_type
m_and_a
sentiment
neutral
materiality_score
0.75
calibrated_materiality_score
0.75
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001437749-26-003620
json_url
https://secwatch.observer/filing/0001437749-26-003620.json
markdown_url
https://secwatch.observer/filing/0001437749-26-003620.md
text_url
https://secwatch.observer/filing/0001437749-26-003620.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/709337/000143774926003620/0001437749-26-003620-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/709337/000143774926003620/fmnb20260209_8k.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null
JSON Markdown Plain text

Source-grounded claims

121789420140d1702c1b0fffc32cc50a5c435014

FARMERS NATIONAL BANC CORP /OH/: Increased authorized common shares from 50,000,000 to 75,000,000 shares.

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

SEC 8-K Item 5.03/5.05/5.06 confidence 0.9 SEC evidence

Comparable filings

ESAB

ESAB completes $1.45B acquisition of Eddyfi Technologies

ESAB Corp June 2, 2026, 6:41 AM ET m_and_a Items 2.01, 3.02, 5.03, 3.03, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

On June 1, 2026, the Company filed the Certificate of Designations with the Delaware Secretary of State to establish the preferences, limitations and relative rights of its 6.50% Series A Mandatory Convertible Preferred Stock (the “ Series A Mandatory Convertible Preferred Stock ”), which became effective upon filing.

Filing page SEC filing

APAD

Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M

Enhanced Group Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

As a result of the Business Combination, the Company ceased being a shell company

Filing page SEC filing

GYRE

Gyre Therapeutics completes $300M all-stock acquisition of Cullgen; appoints Ying Luo as CEO

GYRE THERAPEUTICS, INC. May 4, 2026, 7:59 PM ET m_and_a Items 2.01, 5.03, 1.01, 3.02, 3.03, 5.02, 7.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

The Company has filed with the Secretary of State of the State of Delaware a Certificate of Designation of Preferences, Rights and Limitations of the Company Preferred Stock (the “Certificate of Designation”) in connection with the Merger referenced in Item 1.01 above.

Filing page SEC filing

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

In connection with the Spin-Off, the Board adopted the Code of Conduct, a copy of which is available on New Enviri’s website at www.enviri.com.

Filing page SEC filing

CPRX

Angelini Pharma to acquire Catalyst Pharma for $4.1B ($31.50/share), premium 28% to VWAP

CATALYST PHARMACEUTICALS, INC. May 7, 2026, 7:59 PM ET m_and_a Items 1.01, 5.03, 7.01, 8.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

On May 6, 2026, the Board of Directors approved and adopted an amendment (the “ Forum Selection Amendment ”) to the Company’s existing By-Laws that amends Article VIII, Section 8.1 of the By-Laws of the Company.

Filing page SEC filing

DVN

Devon completes all-stock merger with Coterra; combined company retains DVN ticker

DEVON ENERGY CORP/DE May 7, 2026, 7:59 PM ET m_and_a Items 2.01, 5.02, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

On May 7, 2026, the Company filed an amendment to the Company’s restated certificate of incorporation (the “ Authorized Share Charter Amendment ”), effective as of such date, increasing the number of authorized shares of Company Common Stock from 1,000,000,000 to 2,000,000,000.

Filing page SEC filing

FARM

Farmer Brothers taken private by Royal Cup for $1.29/share; merger closes May 5, 2026

FARMER BROTHERS CO May 5, 2026, 7:59 PM ET m_and_a Items 1.02, 2.01, 3.01, 3.03, 5.01, 5.02, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

the Certificate of Incorporation of the Company that was in effect immediately before the Effective Time was amended and restated to be in the form attached hereto as Exhibit 3.1

Filing page SEC filing

ACR

ACR to acquire external manager ACRES Capital Corp., become internally managed REIT

ACRES Commercial Realty Corp. April 30, 2026, 7:59 PM ET m_and_a Items 1.01, 5.02, 3.02, 5.03, 7.01, 9.01

same fact type: governance_change same SEC item: 5.03, 7.01, 9.01 same event type: m_and_a

This filing

At the 2026 Special Meeting, the Company’s shareholders approved an amendment to Article IV of the Company’s Articles of Incorporation, as amended (the “Articles”), to increase the Company’s authorized common shares from 50,000,000 shares to 75,000,000 shares (the “Common Shares Amendment”).

Comparable filing

the Board of Directors of the Company approved, pursuant to Section 6.2.8 of the Company’s charter (the “Charter”), a decrease in the Stock Ownership Limit, as such term is defined therein, from 9.8% to 4.34% in value or in number of shares, whichever is more restrictive, of any class or series of shares of Capital Stock, as such term is defined therein, of the Company. On April 28, 2026, the Company filed an amendment to the Charter (the “Amendment”) reflecting the change in the Stock Ownership Limit with the State Department of Assessments and Taxation of Maryland, effective at 5:00 p.m. on April 29, 2026.

Filing page SEC filing

Source: SEC EDGAR
accession 0001437749-26-003620
view filing index on sec.gov
view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.